Loading...

Cresco Labs Inc.

CL.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.91
CA$-0.08(-8.08%)

Cresco Labs Inc. (CL.CN) Stock Overview

Explore Cresco Labs Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.4/100

Key Financials

Market Cap307.4M
P/E Ratio-3.15
EPS (TTM)$-0.33
ROE-0.16%
Fundamental Analysis

AI Price Forecasts

1 Week$0.68
1 Month$0.49
3 Months$1.29
1 Year Target$0.12

CL.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cresco Labs Inc. (CL.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.15 and a market capitalization of 307.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

63.82RSI (14)
0.01MACD
32.52ADX
Revenue Growth
-6.04%
↓ 6.04%
Profit Growth
CA$-0.22
↑ 57.59%
EPS Growth
CA$-0.22
↑ 59.26%
Operating Margin
14.81%
↑ 222.17%
ROE
-15.65%
↑ 57.59%
Dividend Yield
0.00%
Analyst Recommendations data is not available for CL.CNAnalyst Recommendations details for CL.CN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

CEO

Charles Bachtell

Employees

2,900

Headquarters

400 West Erie Street, Chicago, IL

Founded

1996

Frequently Asked Questions

;